Navigation Links
Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance
Date:12/10/2009

company's worldwide revenue. Lilly also has one of the largest clinical stage oncology pipelines in the industry, with 23 assets - more than one-third of the total pipeline. The need for new and better treatments is staggering: the World Health Organization estimates 12 million cancer-related deaths per year by 2030.

Over the first three quarters of 2009, Alimta has been the company's fastest growing product, reaching worldwide sales of $1.2 billion. U.S. sales have grown 46 percent, driven by market share growth in nonsquamous non-small cell lung cancer (NSCLC). Outside the U.S., Alimta has grown 37 percent. The company plans to pursue additional indications for Alimta, either as monotherapy, or in combination with other oncolytics.

Gemzar sales have exceeded $1.0 billion in the first three quarters of 2009. In the U.S., Gemzar remains the standard of care for pancreatic cancer, and has held steady in NSCLC. Gemzar lost patent exclusivity in Europe in March of 2009, resulting in rapid generic penetration. Gemzar continues to grow in other markets, including Japan and China.

The company continues to work with its partners, Bristol Myers Squibb and Merck KGaA, to maximize the growth potential of Erbitux. Erbitux is currently approved in certain indications for colorectal cancer and head and neck cancer. It is being studied for additional indications for these cancers, as well as lung cancer, gastric cancer and others.

Key molecules in the oncology business unit pipeline include:

  • Ramucirumab (IMC-1121B) - Enrollment in a global Phase III study in first-line breast cancer is ongoing, and a second Phase III study in gastric cancer began enrollment in October 2009. Two to three additional Phase III ramucirumab studies are projected to begin in 2010. Several additional Phase II trials are expected to be initiated next year, including trials in brain and bladder cancers and additional studies in colorec
    '/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 2014 Blue Bell, Pennsylvania will ... a leading global Contract Research Organization (CRO), is relocating employees from ... locations into new modern Class A+ office space in ... week and marks the first phase of the relocation plan. ... said Harris Koffer , President of the Strategic Solutions Group ...
(Date:8/26/2014)... 2014 Biomedical Research Laboratories (BRL) ( www.brlscience.com ... the prestigious 2014 Inc. 500 list of America,s fastest-growing ... on this prestigious list and ranked among the most ... Biomedical Research Laboratories, CEO. "Today,s announcement represents a major ... the hard work and talent of our team. BRL ...
(Date:8/26/2014)... , Aug. 26, 2014 ... of the "Global Veterinary Diagnostics Market 2014-2018" ... Veterinary diagnostics include various tests, which are used ... livestock producers, and biomedical researchers are mainly availing ... testing (Deoxyribonucleic Acid/Ribonucleic Acid testing), immunodiagnostics, clinical chemistry, ...
Breaking Medicine Technology:PRA Health Sciences Expands in Pennsylvania 2Biomedical Research Laboratories Named to Inc. 500 List of America's Fastest-Growing Companies 2Global Veterinary Diagnostics Market 2014-2018: Key Vendors are Abaxis, Heska, IDEXX Laboratories, Mindray Medical, VCA Antech and Zoetis 2Global Veterinary Diagnostics Market 2014-2018: Key Vendors are Abaxis, Heska, IDEXX Laboratories, Mindray Medical, VCA Antech and Zoetis 3
... LAS VEGAS, May 22 CardioVascular,BioTherapeutics, Inc. (OTC Bulletin ... Christopher Moore to be the sponsor and general,partner of ... of,$1 million and up to $10 million of the ... am extremely impressed with CVBT,s wound healing drug, which ...
... Novavax, Inc. (Nasdaq:,NVAX) today announced that it ... vaccine candidate against Severe Acute Respiratory Syndrome,(SARS). The ... Institutes of Health (NIH) to continue preclinical development ... "Until now, it has been difficult to ...
Cached Medicine Technology:Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 2Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 3Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development 2Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development 3
(Date:8/27/2014)... August 27, 2014 In My Solitude, a ... Collection” to provide a growing number of women from college ... for goal setting and relaxing at the same time. , ... uses scent memory and visualization to help women stay focused ... each time they light a candle and enjoy the fragrance. ...
(Date:8/27/2014)... 2014 Michael A. Bottar ... of The Best Lawyers In America© for the practice ... Injury Litigation - Plaintiffs." , Bottar received his undergraduate ... laude graduate of Syracuse University College of Law where ... Practice" chapter of the Syracuse Law Review Survey of ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 iHire ... practices as the “Most Creative Workplace” in Frederick, ... Best Places to Work Awards. , Held at ... event is a joint partnership between the Frederick ... Economic Development, Frederick County Business Development and Retention, ...
(Date:8/27/2014)... *To find out more about this ... Research on the web ( http://www.achieveclinical.com ) or contact them ... There is no cost to participate , ... Compensation may be provided for time and travel ... there are at least 5 million Americans living with fibromyalgia. ...
(Date:8/26/2014)... BambooIndustry.com, the popular online supplier of bamboo products, has ... for the online market. Along with that, the company ... items are offered at greatly discounted prices, from 15 ... on September 10, 2014. , At present, all ... shipping costs. The company wants to offer an excellent ...
Breaking Medicine News(10 mins):Health News:In My Solitude Unveils Eco Candle Line That May Improve Performance 2Health News:Michael A. Bottar Selected For Inclusion In The Best Lawyers In America© 2015 2Health News:iHire Named Most Creative Workplace in Frederick, MD 2Health News:Achieve Clinical Research Is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial in Birmingham, Alabama 2Health News:Achieve Clinical Research Is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial in Birmingham, Alabama 3Health News:Discounted, High Quality Bamboo Floorings Provided Online By BambooIndustry.com 2
... 10 Nutraceutical International Corporation (Nasdaq: NUTR ) today reported ... 30, 2009. Net sales for the fiscal 2009 fourth quarter ... of fiscal 2008. For the fourth quarter of fiscal 2009, ... compared to net income of $1.5 million, or $0.14 diluted earnings ...
... ... all women using the birth control pills Yaz or Yasmin that they may ... vein thrombosis and other significant side effects as a result of the defective ... and Yasmin —known as drospirenone, or DRSP—has been linked to an increased risk ...
... Given the rising ... be offering free testing for Chlamydia at all six affiliated campuses in the State of ... Research Officer of the Institute in a meeting with health care providers in Polk county ... (Vocus) December 10, ...
... pcRUSH.com ... technology hardware to the various Branches of the United States Federal, State/Local Governments and ... , ... (PRWEB) December 10, 2009 -- pcRUSH.com / Atman, Inc. was recently awarded a General ...
... ... Machine Tool Giveaway contest. The 5 were chosen from a pool of nearly 400 ... accepted in video or essay form. , ... Charlotte, NC (PRWEB) December 10, 2009 -- Okuma America Corporation has announced the ...
... new study to asses patient awareness of medications prescribed during ... a medication they were not, and 96% were unable to ... had been prescribed during hospitalization. These findings are published ... Inpatient medication errors represent an important patient safety issue, with ...
Cached Medicine News:Health News:Nutraceutical Reports Fiscal 2009 Year End Results 2Health News:Nutraceutical Reports Fiscal 2009 Year End Results 3Health News:Nutraceutical Reports Fiscal 2009 Year End Results 4Health News:Nutraceutical Reports Fiscal 2009 Year End Results 5Health News:Nutraceutical Reports Fiscal 2009 Year End Results 6Health News:Nutraceutical Reports Fiscal 2009 Year End Results 7Health News:Nutraceutical Reports Fiscal 2009 Year End Results 8Health News:Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking YAZ or YASMIN 2Health News:Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking YAZ or YASMIN 3Health News:Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking YAZ or YASMIN 4Health News:The Institute of Women's Health of North America to Offer Free Chlamydia Testing at All Affiliated Campuses – Dr. Abdul Rao 2Health News:The Institute of Women's Health of North America to Offer Free Chlamydia Testing at All Affiliated Campuses – Dr. Abdul Rao 3Health News:pcRUSH.com / Atman, Inc. is Awarded General Services Administration (GSA) Schedule (GS-35F-0099W) 2Health News:Okuma Real Help Machine Tool Giveaway Finalists Announced 2Health News:Study highlights lack of patient knowledge regarding hospital medications 2
Provides a combination of concentrated cold / hot and compression for the back...
... One-Piece™ Collar is completely injected molded from ... our patented chin support. , ,Our ... efficiently managed where space is limited. Color-coded ... of sizes., ,Either in a supine ...
... therapy Gel Pad. Our Gel Pad helps defeat ... reduce swelling and /or hot therapy to increase ... hot and cold therapy gel pad, place an ... can be added to each support upon request. ...
... Because when it comes to superior immobilization ... do the job., ,You already know that ... is immobilization of the c-spine. But what you ... that Jerome Medical's NECLOC ®: provides superior immobilization ...
Medicine Products: